Author Contributions: Dr Redwood had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Study concept and design: Perera, Stables, Redwood.
Acquisition of data: Perera, Stables, Thomas, Booth, Pitt, Blackman, de Belder, Redwood.
Analysis and interpretation of data: Perera, Booth, Redwood.
Drafting of the manuscript: Perera, Stables, de Belder, Redwood.
Critical revision of the manuscript for important intellectual content: Perera, Stables, Thomas, Booth, Pitt, Blackman, Redwood.
Statistical analysis: Perera, de Belder.
Obtained funding: Perera, Stables, Thomas, Booth, Redwood.
Administrative, technical, or material support: Perera, Stables, Booth, Pitt, Blackman, Redwood.
Study supervision: Perera, Redwood.
Financial Disclosures: Dr Perera and Dr Redwood reported receiving financial support from the UK Department of Health via the National Institute for Health Research Comprehensive Biomedical Research Centre Award to Guy's & St Thomas' National Health Service Foundation Trust in partnership with King's College London. No other authors reported disclosures.
Funding/Support: This trial was sponsored by the British Cardiovascular Intervention Society, which in turn received funding from Maquet Cardiovascular (previously Datascope) (Mawah, New Jersey), Cordis, and Johnson & Johnson (Wokingham, United Kingdom) by way of unrestricted educational grants, and by Lilly (Hampshire, United Kingdom), which provided abciximab for use in the trial.
Role of the Sponsors: The companies providing funding or support in kind had no role in the design and conduct of the study; the collection, analysis, and interpretation of the data; or the preparation, review, or approval of the manuscript.
Additional Contributions: We gratefully acknowledge the contribution of the independent trial statistician, Winston Banya, MSc (Royal Brompton and Harefield National Health Service Trust, London, United Kingdom), and the data coordination center of the Clinical Trials and Evaluation Unit (Royal Brompton and Harefield National Health Service Trust, London, United Kingdom). Mr Banya received no compensation for his contributions.
A list of the BCIS-1 Investigators has been published previously (Am Heart J. 2009;158:910-916).